Analysts think VNDA stock price could increase by 202%
May 08, 2025, 11:25 AM
4.67%
What does VNDA do
Vanda Pharmaceuticals, headquartered in Washington, D.C., develops therapies for unmet medical needs and has three commercial products, including HETLIOZ and Fanapt. The company also has multiple drugs in development.
5 analysts think VNDA stock price will increase by 202.05%. The current median analyst target is $13.26 compared to a current stock price of $4.39. The lowest analysts target is $5.05 and the highest analyst target is $21.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
